Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, April 28, 2022
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
Wed, April 27, 2022
[ Wed, Apr 27th 2022
] - WOPRAI
[ Wed, Apr 27th 2022
] - WOPRAI
Andrea Tan Initiated (VOR) at Hold and Held Target at $6 on, Apr 27th, 2022
Andrea Tan of Goldman Sachs, Initiated "Vor Biopharma Inc." (VOR) at Hold and Held Target at $6 on, Apr 27th, 2022.
Andrea has made no other calls on VOR in the last 4 months.
There are 2 other peers that have a rating on VOR. Out of the 2 peers that are also analyzing VOR, 0 agree with Andrea's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Andrea
- Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $26 on, Monday, March 21st, 2022
- Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Decreased Target to $30 on, Wednesday, March 16th, 2022
